Now livetag icon
The official Gen AI Landscape report for 2026 is here. Don’t miss out!Get your copybanner icon
Fujirebio

July 2026

Fujirebio Market Share Analysis for July 2026

fujirebio is an r&d-driven company constantly developing new technologies and unique biomarkers with high clinical value. our group mission is to create new value in healthcare and thereby contribute to human health and the future of medical care.
Year Founded1950
Employees1001 - 5000
Annual Revenue--
fujirebio.co.jp
Fujirebio
Fujirebio (including company regionals)
  • fujirebio.co.jp
    fujirebio.co.jp
See more website traffic and engagement information

Total visits to Fujirebio's top domains

Understand Fujirebio market share and potential market reach.

Total visits last 3 months

Subsidiaries Breakdown

Avg. visit duration in Fujirebio's top domains

Analyze Fujirebio engagement metrics.

Average visit duration last 3 months

Subsidiaries Breakdown
fujirebio.co.jpfujirebio.co.jp00:01:14
See more with Sales Intelligence

Avg. pageviews on Fujirebio's top domains

See how Fujirebio keep users engaged, nurture their interest, and encourage them to take the next step.

Average page views last 3 months

Subsidiaries Breakdown

Want to gain deeper traffic insights?

Filter 20.3M+ online businesses. Discover new leads when their traffic spikes, when they start or stop using technologies, or when they get positive press.



Top technologies used by Fujirebio

These are the website technologies, by industry, used by Fujirebio top domains

Advertising (5)

Google Adsense

Google Adsense

Audio Video Media (4)

YouTube

YouTube

Conversion & Analytics (3)

Google Analytics

Google Analytics

Mobile (3)

Meta Viewport

Meta Viewport

More Technologies

8

See all

Ready to discover high quality prospects?

Identify what technologies a website uses to craft the perfect sales pitch, and shorten the sales cycle with the Similarweb Sales Intelligence Solution.


News & Signals from Fujirebio

With Similarweb Sales signals alerts, you’ll receive daily updates of recognized buying signals whenever new opportunities or threats arise in your target audience.

NewsFUJIREBIO Inc. is developing Access portfolio of immunoassay analyzers.Through the partnership, Fujirebio will develop tests on Beckman Coulter's Access portfolio of immunoassay analyzers, with the initial focus on the firm's Dxl 9000 Access Immunoassay Analyzer, the companies said in a statement.

See all Fujirebio signals

Focus your sales teams on the most promising opportunities. By prioritizing opportunities and engaging at the right time, you can optimize efforts and close more deals.